ArticleCell death discovery2026

Long term administration of selective NMDA GluN2B receptor blocker Ro25-6981 attenuates neurodegeneration in mouse model of spinocerebellar ataxia type 1 (SCA1).

Olga S Belozor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.